Insider trades

Hunter C. Smith, CFO of Rhythm Pharmaceuticals RYTM, has filed 0 purchases and 47 sales on the open market. Over the past 12 months that comes to a net sale of $2.2M. The latest trade was on 05/18.

Hunter C. Smith

CFO
First filing
23/02/03
Trades
107 trades
Buys / sales
0 / 47
12-month net buying
−$2.2M
Last trade
05/18

Trading activity

Transactions

Trade type
RYTM
Open-market sale10b5-1 plan02/17–02/1902/197,954 sh9 trades$101.31avg.$805,821.6−6.7%
RYTM
Open-market sale10b5-1 plan02/10–02/1202/127,071 sh10 trades$100.21avg.$708,585.92−5.6%
RYTM
Open-market sale10b5-1 plan02/04–02/0502/066,628 sh4 trades$106.02avg.$702,728.35−5.0%
RYTM
Open-market sale10b5-1 plan25/08/12–25/08/1325/08/1428,088 sh2 trades$96.29avg.$2,704,569.63−19.4%
RYTM
Open-market sale10b5-1 plan25/07/0925/07/1142,120 sh3 trades$80.48avg.$3,389,683.13−26.5%
RYTM
Open-market sale10b5-1 plan25/05/3025/06/0323,400 sh2 trades$61.41avg.$1,436,967.87−17.6%
Open-market sale10b5-1 plan25/02/1925/02/192,215 sh$57.22$126,742.3−2.0%
RYTM
Open-market sale10b5-1 plan25/02/1225/02/14751 sh2 trades$56.39avg.$42,346.85−0.7%
RYTM
Open-market sale10b5-1 plan25/02/1125/02/111,296 sh2 trades$57.51avg.$74,533.06−1.2%
Open-market sale25/02/0425/02/041,678 sh$59.43$99,723.54−1.6%
Open-market sale24/03/1924/03/1915,515 sh$39.22$608,498.3−13.7%
RYTM
Open-market sale24/02/12–24/02/1324/02/131,918 sh2 trades$50.80avg.$97,440.8−2.3%
Open-market sale24/02/0124/02/051,616 sh$45.06$72,816.96−2.1%
RYTM
Open-market sale23/12/05–23/12/0623/12/0727,026 sh2 trades$38.72avg.$1,046,331.56−30.6%
Open-market sale23/11/2423/11/2810,974 sh$35.02$384,309.48−15.2%
Open-market sale23/11/1423/11/1612,000 sh$30.38$364,560−16.3%
RYTM
Open-market saleAmendment23/02/09–23/02/1423/02/142,115 sh2 trades$27.30avg.$57,734.37−3.4%
Open-market sale23/02/0923/02/131,398 sh$27.66$38,668.68−2.4%